Generic drug sponsors deviating from US Pharmacopeia standards can now petition for a monograph change before receiving application approval, a practice the US Food and Drug Administration endorses as part of its effort to lower drug costs.
New FDA draft guidance released 10 July encourages ANDA sponsors that will need to request changes to the official...